Pre-Filled Pen
Research use onlyACE-031 1.66mg / 1mL
VAT included. Shipping calculated at checkout.
In stock
- ≥99% purity
- HPLC & LC-MS analysed
- Stabilised formula
- The world's first brand of peptides in a pen
Secure delivery
Secure delivery with FedEx within 1–2 business days after payment confirmation
Payment methods
- Bank transfer
What is ACE-031?
ACE-031 is a recombinant protein and peptide-based derivative developed as a selective myostatin inhibitor. Myostatin is a protein that limits muscle mass growth. By blocking its activity, ACE-031 has attracted considerable attention in the scientific community as a research tool for muscle hypertrophy, recovery after injuries, and metabolic regulation.
ACE-031 is produced by combining a portion of the myostatin receptor (ActRIIB) with an Fc fragment of human immunoglobulin. This structure enables it to bind to and neutralise myostatin, creating conditions that promote muscle mass and strength development.
What are the benefits of the ACE-031 peptide?
ACE-031 is considered a peptide with significant potential, particularly in muscle and metabolic research. Some of the most notable benefits described in scientific publications include:
1. Promotion of muscle growth
As a myostatin inhibitor, ACE-031 supports muscle mass growth by reducing the activity of the protein that limits this growth. This makes it a valuable tool in studies investigating muscle hypertrophy.
2. Improvement of muscle strength
Increased muscle mass, combined with optimised muscle fibre function, may contribute to greater strength and endurance – important parameters in sports physiology and rehabilitation research.
3. Recovery after injuries
ACE-031 is being investigated for its potential to accelerate muscle recovery following injuries, surgical procedures, or degenerative processes. This is associated with the stimulation of protein synthesis and cellular regeneration processes.
4. Improvement of the metabolic profile
There is evidence suggesting that ACE-031 may influence metabolism by optimising energy utilisation and improving insulin sensitivity. This makes it an interesting subject for studies on metabolic syndrome and obesity.
5. Potential in degenerative muscle diseases
ACE-031 is also being investigated in research on rare muscle diseases. Its mechanism of action suggests a possible role in conditions associated with muscle loss.
6. Support for healthy ageing
By promoting muscle growth and optimising metabolism, ACE-031 may also be considered in the context of ageing research, particularly regarding the preservation of muscle strength in older adults.
Mechanism of action of the ACE-031 peptide:
The mechanism of action of ACE-031 is based on blocking myostatin, a protein belonging to the TGF-β family that plays a key role in limiting muscle mass. By binding to myostatin and preventing its interaction with receptors, ACE-031 enables the activation of cellular signalling pathways that promote muscle fibre growth and differentiation.
Furthermore, ACE-031 may also affect other ligand pathways within the TGF-β family, expanding its biological activity. This explains the scientific interest in this peptide not only in the field of muscle growth but also in metabolic and regenerative research.
Proper use and dosage of ACE-031:
1 unit = 16.6 mcg
Total amount per pen: 100 units (1.66 mg)
The appropriate administration and dosage of ACE-031 depend on specific needs and objectives; doses of 1 to 3 mcg per kilogram of body weight are typically used.
Example of ACE-031 administration for a body weight of 90 kg, based on 2 mcg per kilogram of body weight:
90 kg × 2 mcg = 180 mcg daily, equivalent to 11 units per day (considering that one unit contains 16.6 mcg).
Example of ACE-031 administration for a body weight of 75 kg, based on 2 mcg per kilogram of body weight:
75 kg × 2 mcg = 150 mcg daily, equivalent to 9 units per day (considering that one unit contains 16.6 mcg).
The duration of a cycle with this peptide is 15–20 days, depending on the needs and objectives of the research protocol.
Research on ACE-031 in various fields:
ACE-031 has been investigated across numerous scientific disciplines highlighting its role as a myostatin inhibitor:
- Muscle physiology – focusing on increasing muscle mass and strength.
- Rehabilitation medicine – the peptide is being considered as a potential agent for accelerating recovery after injuries and surgical procedures.
- Metabolic research – investigating its potential effects on insulin sensitivity and energy balance.
- Gerontology – its potential role in preserving muscle strength in older adults is of particular interest.
- Rare diseases – certain research protocols investigate ACE-031 in connection with conditions associated with muscle atrophy.
Possible side effects of ACE-031:
ACE-031 is generally considered well tolerated within scientific research protocols. Possible side effects are described as rare and usually mild:
- Mild redness or discomfort at the injection site.
- Headaches – short-lasting and mild in intensity.
- Fatigue – temporary changes in energy levels in some users.
- Changes in appetite – possible mild fluctuations.
- Mild sleep disturbances – temporary and usually resolving quickly.
These reactions are limited and generally resolve quickly. Overall, ACE-031 demonstrates a favourable tolerability profile in scientific investigations.













